In March 2025, the company declared new plans for a direct-to-consumer presenting of its Wegovy weight loss drug. The company proven a whole new pharmacy, termed NovoCare, which might cost clients $499 a month for usage of the drug, less than 50 % the expense of the drug by other pharmaceutical